Drugs · Brain health technique

Antihypertensives

Evidence grade: Context Dependent

Illustration for Antihypertensives

Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers (amlodipine, diltiazem), thiazide diuretics (chlorthalidone, hydrochlorothiazide), and beta-blockers (metoprolol, carvedilol).

Practice
Drugs
Principle
Treatment
Tactic
Metabolic & Vascular Optimization Drugs
Health domains
vascular
Evidence grade
Context Dependent
Strength of evidence
Medium
Cost
High
Effort
Low
Time commitment
Low

How to practice Antihypertensives

Monitor blood pressure regularly and work with a clinician to tailor therapy. Combine medication with diet (DASH or Mediterranean), sodium reduction, and regular physical activity. Early and sustained control in midlife provides the greatest cognitive benefit. Avoid overtreatment causing hypotension, which can reduce brain perfusion.

The evidence behind Antihypertensives

High blood pressure is a leading risk factor for heart attack, stroke, and kidney disease. Lowering blood pressure with medicine reduces the risk of heart attack and stroke. These drugs help keep your blood vessels flexible and blood flowing through your smallest vessels. The evidence for these benefits is robust and consistent.

Impact on brain health

High blood pressure is one of the strongest modifiable risk factors for dementia and cognitive decline. Trials in adults with high blood pressure show that treating to a systolic pressure (the top number) below 120 mmHg lowers the risk of mild cognitive impairment more than a standard target does. The same trials show less white-matter damage, likely because steady blood flow means fewer oxygen shortages and less inflammation in brain cells.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

  • Evidence grade: Context Dependent

    Lipid-Lowering Drugs

    Therapies that reduce LDL cholesterol and vascular inflammation, including statins (atorvastatin, rosuvastatin, simvastatin), PCSK9 inhibitors (alirocumab, evolocumab), and ezetim…

    Low effort · High cost

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing